Related Experiment Videos
NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.
Martina Fantin1, Matteo Marti, Yves P Auberson
1Department of Experimental and Clinical Medicine, Section of Pharmacology, and Istituto Nazionale di Neuroscience, University of Ferrara, Ferrara, Italy.
Journal of Neurochemistry
|November 8, 2007
Summary
Striatal NMDA receptors with NR2A and NR2B subunits regulate specific projection neurons. NR2A impacts striato-pallidal pathways, while NR2B influences striato-nigral pathways, affecting GABA and glutamate release.
Area of Science:
- Neuroscience
- Neuropharmacology
- Basal Ganglia Function
Background:
- NMDA receptors are crucial for neuronal signaling in the basal ganglia.
- Striatal projection neurons, including striato-pallidal and striato-nigral neurons, play key roles in motor control.
- The specific roles of NR2A and NR2B subunits of NMDA receptors in regulating these projection neurons are not fully elucidated.
Purpose of the Study:
- To investigate the role of striatal NR2A and NR2B subunit-containing NMDA receptors in regulating striato-pallidal and striato-nigral projection neurons.
- To differentiate the functions of NR2A and NR2B subunits in both tonic and phasic neurotransmission.
Main Methods:
- Triple probe microdialysis in rat striatum, globus pallidus, and substantia nigra.
- Perfusion of selective NR2A antagonist (NVP-AAM077) and NR2B antagonist (Ro 25-6981) into the striatum.
- Administration of tetrodotoxin to assess tonic activity.
- Challenging with NMDA to investigate phasic activation.
Main Results:
- NR2A antagonism reduced pallidal GABA and increased nigral glutamate release.
- NR2B antagonism reduced nigral GABA and increased striatal/pallidal glutamate release.
- Both antagonists blocked NMDA-induced striatal GABA release; NR2A antagonist affected globus pallidus, while NR2B antagonist affected substantia nigra.
Conclusions:
- Striatal NR2A-containing NMDA receptors preferentially regulate striato-pallidal neurons.
- Striatal NR2B-containing NMDA receptors preferentially regulate striato-nigral neurons.
- These findings highlight subunit-specific roles in basal ganglia circuitry and neurotransmission.
Related Concept Videos
Cholinergic Receptors: Nicotinic
5.1K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
5.1K
Adrenergic Receptors: β Subtype
3.3K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.3K
Drugs Acting on Autonomic Ganglia: Stimulants
2.0K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.0K
Transducer Mechanism: Nuclear Receptors
2.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.3K
The Two-State Receptor Model
2.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.9K
Adrenergic Receptors: ɑ Subtype
2.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.6K